USANA Health Sciences (NYSE:USNA) Price Target Raised to $38.00

USANA Health Sciences (NYSE:USNA - Get Free Report) had its price target hoisted by DA Davidson from $35.00 to $38.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a "neutral" rating on the stock. DA Davidson's price objective indicates a potential upside of 4.42% from the company's current price.

Separately, StockNews.com upgraded shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a research note on Saturday, December 28th.

USANA Health Sciences Price Performance

Shares of NYSE:USNA traded up $0.50 during trading on Thursday, reaching $36.39. 129,382 shares of the company's stock traded hands, compared to its average volume of 84,571. The stock has a market capitalization of $693.59 million, a P/E ratio of 12.86, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. USANA Health Sciences has a 12 month low of $31.44 and a 12 month high of $54.45. The company has a 50 day moving average of $37.90 and a 200-day moving average of $39.68.

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period in the prior year, the company earned $0.59 earnings per share. Equities research analysts predict that USANA Health Sciences will post 2.45 earnings per share for the current fiscal year.

Insider Buying and Selling

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the company's stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company's stock.

Institutional Trading of USANA Health Sciences

A number of hedge funds and other institutional investors have recently modified their holdings of USNA. Franklin Resources Inc. increased its stake in USANA Health Sciences by 9.2% in the 3rd quarter. Franklin Resources Inc. now owns 21,050 shares of the company's stock worth $750,000 after purchasing an additional 1,771 shares in the last quarter. Barclays PLC grew its stake in USANA Health Sciences by 111.9% in the third quarter. Barclays PLC now owns 27,737 shares of the company's stock valued at $1,052,000 after purchasing an additional 14,647 shares in the last quarter. Geode Capital Management LLC increased its holdings in USANA Health Sciences by 4.5% in the third quarter. Geode Capital Management LLC now owns 297,120 shares of the company's stock worth $11,269,000 after buying an additional 12,898 shares during the last quarter. State Street Corp raised its holdings in shares of USANA Health Sciences by 0.6% during the 3rd quarter. State Street Corp now owns 435,164 shares of the company's stock valued at $16,501,000 after purchasing an additional 2,782 shares in the last quarter. Finally, Safe Harbor Fiduciary LLC acquired a new stake in shares of USANA Health Sciences in the third quarter worth about $30,000. Institutional investors own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.